| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |